IMUX Immunic Therapeutics Net earnings per share growth forecast for next year
Changes in earnings per share target estimates correlate with the Immunic, Inc. (IMUX) strategy of attracting top immunologists via RSU options to develop oral medications. Meanwhile, 33.80 represents the current value of the metric amid the gradual depletion of liquidity for global trials. Fundamental stability is supported by partnerships with medical centers in the therapy of inflammatory bowel disease and multiple sclerosis.
Analytical breakdowns for Immunic, Inc.
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- earnings and valuation multiples information:
IMUX - Net Financial Result|Projected Future Earnings Immunic, Inc.|IMUX - Price to Earnings Ratio|Projected Price to Earnings Immunic Therapeutics|IMUX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Immunic|IMUX - Operating income before deduction of amortization|Earnings per share for the last twelve months Immunic|IMUX - Earnings per share for the last 12 months|Quarterly EPS earnings growth immunic-therapeutics.com|IMUX - Net earnings per share growth this year|Expected earnings per share growth for next year Immunic, Inc.
Comprehensive company analysis:Immunic, Inc.
The stability of Immunic, Inc. (IMUX) is based on liquidity and Daniel Vittorius's success in developing multiple sclerosis therapies. The mathematical basis of the metric aggregates expert consensus forecasts for net income changes, assessing the future efficiency of the business model. This indicator reveals hidden imbalances; therefore, a decrease in the projected earnings per share growth for the next fiscal year signals a potential weakening of fundamental strength.
Main competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Grifols Biemat GRFS|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year celldex.com|Net earnings per share growth forecast for next year Aurinia Pharmaceuticals Inc.|Expected earnings per share growth for next year BioCryst Pharmaceuticals, Inc. (BCRX)|Expected earnings per share growth for next year VERA (Vera Pharma)|Earnings growth forecast for next year Dianthus Corp (DNTH)|Net earnings per share growth forecast for next year Pharvaris N.V. PHVS|ABCL: Projected earnings per share growth rate for next year|Tourmaline Bio - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Precigen Inc PGEN|PHAR: Earnings growth forecast for next year|Expected earnings per share growth for next year Nektar Corp|Expected earnings per share growth for next year UPB|ZBIO: Expected earnings per share trend next year|Earnings growth forecast for next year IMNM|Consensus forecast of earnings per share growth for next year Gossamer Bio Inc|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|SEPN: Projected earnings per share growth rate for next year|Pieris Pharmaceuticals - Earnings growth forecast for next year|savarapharma.com (SVRA) - Expected earnings per share growth for next year|RIGL (Rigel Pharmaceuticals, Inc.) - Expected earnings per share growth for next year|ANAB - Consensus forecast of earnings per share growth for next year|ATXS (Astria Pharma) - Earnings growth forecast for next year|enGene Corp (ENGN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year RAPT Therapeutics, Inc. (RAPT)|Expected earnings per share growth for next year aerovatetx.com JBIO|Aclaris Therapeutics, Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year Kyverna Therapeutics Inc. KYTX|TLSA: Expected earnings per share growth for next year|CABA (Cabaletta Bio Inc) - Projected earnings per share growth rate for next year|Ventyx Biosciences (VTYX) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year THTX (theratech.com)|AVTX (Avalo Therapeutics) - Earnings growth forecast for next year|ELDN: Expected earnings per share trend next year|Earnings growth forecast for next year AGEN|Earnings growth forecast for next year Climb Bio, Inc (CLYM)|Net earnings per share growth forecast for next year Zura Bio Limited ZURA|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|ImageneBio Inc (IMA) - Expected earnings per share growth for next year|STTK: Earnings growth forecast for next year|Equillium (EQ) - Earnings growth forecast for next year|Expected earnings per share growth for next year CNTB|ATRA: Expected earnings per share trend next year|Earnings growth forecast for next year IFRX|Consensus forecast of earnings per share growth for next year X4 Pharmaceuticals Inc.|Net earnings per share growth forecast for next year Adicet Bio, Inc. ACET|CELU - Expected earnings per share growth for next year|INMB - Net earnings per share growth forecast for next year|barinthusbio.com (BRNS) - Expected earnings per share growth for next year|KZR (Kezar Life Sciences, Inc.) - Expected earnings per share growth for next year|SAB Biotherapeutics Inc. (SABS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Akari Therapeutics plc|Projected earnings per share growth rate for next year ENLV (Enlivex Therapeutics, Ltd.)|Earnings growth forecast for next year QTTB|GOVX - Expected net earnings per share growth next year|Earnings growth forecast for next year EDSA (Edesa Biotech)|Consensus forecast of earnings per share growth for next year iBio Inc (IBIO)|CARM - Net earnings per share growth forecast for next year|XTL Bio (XTLB) - Expected earnings per share growth for next year|boltbio.com (BOLT) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year HCW Biologics|Expected earnings per share growth for next year APVO|Earnings growth forecast for next year AIM ImmunoTech, Inc.|Net earnings per share growth forecast for next year Aditxt (ADTX)|GRI Bio Corporation - Projected earnings per share growth rate for next year|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc.)|Consensus forecast of earnings per share growth for next year reshapelifesciences.com (HIND)|Revelation Biosciences, Inc. - Earnings growth forecast for next year|Indaptus Therapeutics Inc (INDP) - Expected earnings per share growth for next year|SCNI (Scinai) - Expected earnings per share growth for next year|CalciMedica - Expected earnings per share trend next year|AFMD (Affimed NV) - Earnings growth forecast for next year|Allakos Therapeutics (ALLK) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|igmbio.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year ITOS (iTeos)|OCEA - Expected earnings per share growth for next year|TCBP: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year thirdharmonicbio.com THRD
